tesa Labtec GmbH - Solutions for Pharma

Focus on transdermal systems and
oral dissolvable films

Welcome to tesa Labtec! We are a drug delivery company with a focus on transdermal and topical patches (Transfilm®) as well as fast dissolving oral films (Rapidfilm®). Our company offers innovative dosage forms and technolgies paired with comprehensive contract development and manufacturing services.
Partner with us and benefit from our “Solutions for Pharma”.
0Contact us.+49 (2173) 9735-0

Profile

Profile_3.tif

Focus on transdermal systems and oral films

tesa Labtec is a drug delivery company with a specific focus on transdermal and topical patches (Transfilm®) as well as oral films (Rapidfilm® and Mucofilm®). A wholly owned subsidiary of tesa SE and part of the Beiersdorf group of companies, tesa Labtec represents the pharmaceutical business in a truly global family of companies offering „Solutions for Pharma“.
More information

History

Strong and knowledgeable production team

tesa Labtec GmbH

With more than 20 years of experience in the development of transdermal and topical patches, tesa Labtec today is one of the leading drug delivery development companies in Europe. Comprehensive expertise in the development of oral dissolvable films gained over the last decade complements tesa Labtec`s capabilities to offer a broad technology portfolio to its customers.
More information

How to find us

How to find us

How to find us

The tesa Labtec headquarters and laboratories are located in Langenfeld (Germany), between Düsseldorf and Cologne. The production site and clean room facilities are situated in Hamburg within the local tesa plant.
More information

CURRENT OPENINGS

04/05/18 Laborleiter (m/w) Formulierungsentwicklung
An unserem Standort in Langenfeld / Rheinland suchen wir zum nächstmöglichen Zeitpunkt einen Laborleiter (m/w) Formulierungsentwicklung
More information

PRESS CENTER

02/13/18 EsoCap AG and tesa Labtec GmbH sign development cooperation agreement for a smart application technology in the upper gastrointestinal tract
EsoCap AG and tesa Labtec GmbH announced that they have entered into a cooperation on the industrial development of a unique drug delivery technology for diseases of the upper astrointestinal tract. This collaboration leverages the collective expertise of a strong partner in the thin film technology with an innovative biopharmaceutical company.
More information